France 24

FDA approves new drug Rasonque to treat advanced pancreatic cancer

FDA approves new drug Rasonque to treat advanced pancreatic cancerWorldPing

The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease.

This is a short WorldPing brief. The full report was published by France 24.

Read the full report at France 24

Related news